CRCAM BRIE PIC2-CCI (CRBP2.PA) Stock Fundamental Analysis
Europe - EPA:CRBP2 - FR0010483768 - Common Stock
29.895 EUR
+0.89 (+3.07%)
We assign a fundamental rating of 2 out of 10 to CRBP2. CRBP2 was compared to 97 industry peers in the Banks industry. CRBP2 has a bad profitability rating. Also its financial health evaluation is rather negative. CRBP2 is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
CRBP2 had positive earnings in the past year.
CRBP2 had a negative operating cash flow in the past year.
Each year in the past 5 years CRBP2 has been profitable.
The reported operating cash flow has been mixed in the past 5 years: CRBP2 reported negative operating cash flow in multiple years.
1.2 Ratios
CRBP2 has a Return On Assets of 0.53%. This is in the lower half of the industry: CRBP2 underperforms 60.82% of its industry peers.
CRBP2's Return On Equity of 3.86% is on the low side compared to the rest of the industry. CRBP2 is outperformed by 74.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.53% | ||
| ROE | 3.86% | ||
| ROIC | N/A |
ROA(3y)0.47%
ROA(5y)0.46%
ROE(3y)3.92%
ROE(5y)3.92%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Profit Margin value of 26.10%, CRBP2 is doing good in the industry, outperforming 71.13% of the companies in the same industry.
CRBP2's Profit Margin has declined in the last couple of years.
CRBP2 does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 26.1% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-6.32%
PM growth 5Y-2.49%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
CRBP2 does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CRBP2 has been reduced compared to 1 year ago.
The number of shares outstanding for CRBP2 has been increased compared to 5 years ago.
Compared to 1 year ago, CRBP2 has an improved debt to assets ratio.
2.2 Solvency
CRBP2 has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
CRBP2 has a better Debt to Equity ratio (0.20) than 87.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | N/A | ||
| Altman-Z | N/A |
ROIC/WACCN/A
WACC5.96%
2.3 Liquidity
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
3. Growth
3.1 Past
CRBP2 shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.82%.
Measured over the past 5 years, CRBP2 shows a small growth in Earnings Per Share. The EPS has been growing by 1.97% on average per year.
CRBP2 shows a decrease in Revenue. In the last year, the revenue decreased by -1.48%.
Measured over the past years, CRBP2 shows a small growth in Revenue. The Revenue has been growing by 4.72% on average per year.
EPS 1Y (TTM)7.82%
EPS 3Y-3.01%
EPS 5Y1.97%
EPS Q2Q%14.31%
Revenue 1Y (TTM)-1.48%
Revenue growth 3Y3.81%
Revenue growth 5Y4.72%
Sales Q2Q%-1.45%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 7.44, the valuation of CRBP2 can be described as very cheap.
Based on the Price/Earnings ratio, CRBP2 is valued cheaper than 87.63% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.10. CRBP2 is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.44 | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)3.77
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
CRBP2 has a Yearly Dividend Yield of 3.76%.
CRBP2's Dividend Yield is comparable with the industry average which is at 4.80.
CRBP2's Dividend Yield is rather good when compared to the S&P500 average which is at 2.37.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.76% |
5.2 History
The dividend of CRBP2 has a limited annual growth rate of 1.20%.
Dividend Growth(5Y)1.2%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
CRBP2's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPA:CRBP2 (10/31/2025, 7:00:00 PM)
29.895
+0.89 (+3.07%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)
Earnings (Next)
Inst Owners3.86%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap478.62M
Revenue(TTM)837.21M
Net Income(TTM)218.51M
Analysts83.64
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.76% |
Yearly Dividend0.71
Dividend Growth(5Y)1.2%
DPN/A
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.44 | ||
| Fwd PE | N/A | ||
| P/S | 0.57 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.08 | ||
| P/tB | 0.08 | ||
| EV/EBITDA | N/A |
EPS(TTM)4.02
EY13.45%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-27.7
FCFYN/A
OCF(TTM)-26.94
OCFYN/A
SpS52.29
BVpS353.77
TBVpS353.75
PEG (NY)N/A
PEG (5Y)3.77
Graham Number178.88
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.53% | ||
| ROE | 3.86% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 26.1% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)0.47%
ROA(5y)0.46%
ROE(3y)3.92%
ROE(5y)3.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-6.32%
PM growth 5Y-2.49%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.02
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 59.41% | ||
| Cap/Sales | 1.46% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | N/A | ||
| Quick Ratio | N/A | ||
| Altman-Z | N/A |
F-Score5
WACC5.96%
ROIC/WACCN/A
Cap/Depr(3y)66.63%
Cap/Depr(5y)90.89%
Cap/Sales(3y)1.62%
Cap/Sales(5y)2.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.82%
EPS 3Y-3.01%
EPS 5Y1.97%
EPS Q2Q%14.31%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.48%
Revenue growth 3Y3.81%
Revenue growth 5Y4.72%
Sales Q2Q%-1.45%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y81.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82.29%
OCF growth 3YN/A
OCF growth 5YN/A
CRCAM BRIE PIC2-CCI / CRBP2.PA FAQ
What is the ChartMill fundamental rating of CRCAM BRIE PIC2-CCI (CRBP2.PA) stock?
ChartMill assigns a fundamental rating of 2 / 10 to CRBP2.PA.
Can you provide the valuation status for CRCAM BRIE PIC2-CCI?
ChartMill assigns a valuation rating of 2 / 10 to CRCAM BRIE PIC2-CCI (CRBP2.PA). This can be considered as Overvalued.
What is the profitability of CRBP2 stock?
CRCAM BRIE PIC2-CCI (CRBP2.PA) has a profitability rating of 2 / 10.
What are the PE and PB ratios of CRCAM BRIE PIC2-CCI (CRBP2.PA) stock?
The Price/Earnings (PE) ratio for CRCAM BRIE PIC2-CCI (CRBP2.PA) is 7.44 and the Price/Book (PB) ratio is 0.08.
How financially healthy is CRCAM BRIE PIC2-CCI?
The financial health rating of CRCAM BRIE PIC2-CCI (CRBP2.PA) is 2 / 10.